Mariangela Gaudio

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.

Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.

Journal: Tumori

Published: July 31, 2026

Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials.

Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials.

Journal: Current oncology (Toronto, Ont.)

Published: May 05, 2026

From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.

From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.

Journal: Tumori

Published: December 15, 2025

Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Journal: JCO clinical cancer informatics

Published: November 06, 2025

[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?

[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?

Journal: La Radiologia medica

Published: April 15, 2025

RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.

RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.

Journal: ESMO open

Published: March 20, 2025

Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses.

Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses.

Journal: Cancers

Published: February 11, 2025

Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists.

Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists.

Journal: Critical reviews in oncology/hematology

Published: October 03, 2024

Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.

Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.

Journal: The oncologist

Published: September 30, 2024

Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients.

Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients.

Journal: The oncologist

Published: September 23, 2024

Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.

Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.

Journal: Cancer treatment reviews

Published: April 05, 2024

Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems.

Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems.

Journal: Digital health

Published: January 20, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026